Endonovo Therapeutics Inc (ENDV)

[Doyle McBoyle1]

In any other going concern it stated the debt they were taking on, that’s your opinion if they’re gloomier or not, but that fact is it hasn’t ever said that their ability to continue is at risk because of debts that need to be paid back and the only revenue stream is sofpulse, I also stated that yes if the sofpulse sales are good then there’s nothing to it but if they fall short it’s gonna be a long, long waiting game with endv because it’s gonna be and endless game of them taking every bit of profit to pay back due debts